Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinician-reviewed guide to tadalafil pharmacogenomics, dosing, and safety considerations specific to patients of Black or African ancestry, with ethnicity-stratified data, guideline citations, and practical prescribing guidance.
Read clinical reviewA clinician-reviewed guide to tadalafil pharmacogenomics, dosing adjustments, and safety considerations specific to East Asian patients, with ethnicity-stratified data and guideline citations.
Read clinical reviewA clinical deep-dive into why tadalafil 2.5 to 20 mg may perform differently in Hispanic and Latino men, covering pharmacogenomics, diabetes-driven comorbidities, ethnicity-stratified trial data, and practical dosing guidance.
Read clinical reviewA clinician-reviewed guide to tadalafil pharmacogenomics, dosing, and safety considerations specific to Hispanic and Latino patients, including CYP3A4/CYP3A5 variants, diabetes comorbidity, and ethnicity-stratified trial data.
Read clinical reviewEvidence-based review of tadalafil efficacy in Black and African ancestry populations, covering pharmacogenomic differences, ethnicity-stratified trial data, CYP3A4 variants, and clinical dosing guidance.
Read clinical reviewEvidence-based review of how tadalafil 2.5-20 mg performs in South Asian populations, including pharmacogenomic variability, dosing considerations, and cardiovascular risk overlap.
Read clinical review